Where Will Kestra Medical Stock Be in 1 Year?
Kestra Medical Technologies (NASDAQ:KMTS) is a medical device startup that…
Buy
60
ROK Quote, Financials, Valuation and Earnings
Last price:
$326.06
Seasonality move
:
0.65%
Day range:
$316.84 - $323.93
52-week range:
$215.00 - $328.90
Dividend yield:
1.6%
P/E ratio:
40.78x
P/S ratio:
4.62x
P/B ratio:
10.61x
Volume:
575.8K
Avg. volume:
894.7K
1-year change:
25.26%
Market cap:
$36.5B
Revenue:
$8.3B
EPS (TTM):
$7.94
Analysts' Opinion
-
Consensus RatingRockwell Automation has received a consensus rating of Hold. The company's average rating is a Hold based on 10 Buy ratings, 13 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $317.12, Rockwell Automation has an estimated downside of -2.07% from its current price of $323.81.
-
Price Target UpsideAccording to analysts, the highest upside price target is $371.00 representing 14.57% upside increase from its current price of $323.81.
Fair Value
-
According to the consensus of 23 analysts, Rockwell Automation has -2.07% downside to fair value with a price target of $317.12 per share.
ROK vs. S&P 500
-
Over the past 5 trading days, Rockwell Automation has overperformed the S&P 500 by 1.13% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Rockwell Automation does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Rockwell Automation revenues have been falling on a year-over-year basis for 5 quarters in a row. In the most recent quarter Rockwell Automation reported revenues of $2B.
Earnings Growth
-
Rockwell Automation earnings have been falling on a year-over-year basis for 7 quarters in a row. In the most recent quarter Rockwell Automation reported earnings per share of $2.22.
Enterprise value:
39.9B
EV / Invested capital:
5.48x
Price / LTM sales:
4.62x
EV / EBIT:
33.21x
EV / Revenue:
5.01x
PEG ratio (5yr expected):
--
EV / Free cash flow:
37.32x
Price / Operating cash flow:
34.45x
Enterprise value / EBITDA:
26.25x
Gross Profit (TTM):
$3.1B
Return On Assets:
8.14%
Net Income Margin (TTM):
11.38%
Return On Equity:
25.11%
Return On Invested Capital:
12.48%
Operating Margin:
17.04%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $8.4B | $9B | $8B | $2.1B | $2B | |
| Gross Profit | $3.4B | $3.6B | $3.1B | $833M | $810M | |
| Operating Income | $1.5B | $1.6B | $1.2B | $332M | $341M | |
| EBITDA | $1.9B | $1.8B | $1.5B | $431M | $419M | |
| Diluted EPS | $11.36 | $10.23 | $7.94 | $2.31 | $2.22 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $3B | $3.3B | $4.1B | $4.1B | $3.8B | |
| Total Assets | $8.3B | $10.7B | $11.5B | $11.4B | $11B | |
| Current Liabilities | $2.1B | $3B | $3.8B | $3.7B | $3.6B | |
| Total Liabilities | $6.2B | $7.8B | $8B | $7.6B | $7.4B | |
| Total Equity | $2.1B | $2.9B | $3.4B | $3.7B | $3.6B | |
| Total Debt | $2B | $4.1B | $4B | $3.7B | $3.7B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $997.7M | $1.3B | $1.3B | $120M | $199M | |
| Cash From Investing | $117.4M | -$2.2M | -$228.5M | -$59M | -$39M | |
| Cash From Financing | -$1.1B | -$1.3B | -$1.1B | -$25M | -$191M | |
| Free Cash Flow | $882.9M | $1.1B | $1.1B | $69M | $171M | |
ROK
Sector
Market Cap
$36.5B
$611.3M
Price % of 52-Week High
98.45%
78.34%
Dividend Yield
1.6%
0%
Shareholder Yield
3.53%
2.29%
1-Year Price Total Return
25.26%
-1.15%
Beta (5-Year)
1.378
0.777
Dividend yield:
1.6%
Annualized payout:
$5.00
Payout ratio:
64.05%
Growth streak:
15 years
Technicals
8-day SMA
Buy
Level
$322.47
200-day SMA
Buy
Level
$278.34
Bollinger Bands (100)
Buy
Level
249.22 - 309.34
Chaikin Money Flow
Buy
Level
331.6M
20-day SMA
Buy
Level
$319.42
Relative Strength Index (RSI14)
Buy
Level
66.54
ADX Line
Buy
Level
32.78
Williams %R
Neutral
Level
-34.8869
50-day SMA
Buy
Level
$287.02
MACD (12, 26)
Buy
Level
8.59
25-day Aroon Oscillator
Buy
Level
48
On Balance Volume
Neutral
Level
218.9M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.7447)
Sell
CA Score
(Annual)
Level (-0.533)
Buy
Beneish M-Score
(Annual)
Level (-2.5299)
Buy
Momentum Score
Level (4)
Sell
Ohlson Score
Level (0.4526)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
With roots tracing back to the early 1900s, Rockwell Automation is the successor to Rockwell International, which spun off its avionics segment in 2001. It is a pure-play industrial automation company that operates through three segments. Its largest segment by revenue, intelligent devices, sells factory floor-level devices such as motors, drives, sensors, relays, and actuators. Its software and control segment sells visualization, simulation, and human-machine interface software and control products such as programmable controllers, computers, and operator terminals. Its smallest segment, lifecycle services, offers digital consulting, engineered-to-order services, and other outsourced services such as remote monitoring, cybersecurity, and asset and plant maintenance and optimization.
Stock Forecast FAQ
In the current month, ROK has received 10 Buy ratings 13 Hold ratings, and 0 Sell ratings. The ROK average analyst price target in the past 3 months is $317.12.
-
Where Will Rockwell Automation Stock Be In 1 Year?
According to analysts, the consensus estimate is that Rockwell Automation share price will drop to $317.12 per share over the next 12 months.
-
What Do Analysts Say About Rockwell Automation?
Analysts are divided on their view about Rockwell Automation share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Rockwell Automation is a Sell and believe this share price will rise from its current level to $229.00.
-
What Is Rockwell Automation's Price Target?
The price target for Rockwell Automation over the next 1-year time period is forecast to be $317.12 according to 23 Wall Street analysts, 10 of them rate the stock a Buy, 0 rate the stock a Sell, and 13 analysts rate the stock a Hold.
-
Is ROK A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Rockwell Automation is a Hold. 13 of 23 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of ROK?
You can purchase shares of Rockwell Automation via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Rockwell Automation shares.
-
What Is The Rockwell Automation Share Price Today?
Rockwell Automation was last trading at $326.06 per share. This represents the most recent stock quote for Rockwell Automation. Yesterday, Rockwell Automation closed at $323.81 per share.
-
How To Buy Rockwell Automation Stock Online?
In order to purchase Rockwell Automation stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Howard Marks Buy Grab Stock?
When a legendary value investor who cut his teeth in…
Why Did Warren Buffett Buy Amazon Stock?
When investors think of tech stocks in Warren Buffett’s portfolio,…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 41x
Buy
59
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 49x
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
88
CDTX alert for Jun 24
Cidara Therapeutics [CDTX] is up 3.18% over the past day.
Sell
46
HIMS alert for Jun 24
Hims & Hers Health [HIMS] is up 2.26% over the past day.
Buy
67
WGS alert for Jun 24
GeneDx Holdings [WGS] is up 13.99% over the past day.
